Human Health and Potential (HHP)

Molecular simulations uncover a new druggable pocket in SARS-CoV-2’s spike protein which could hold the key to blocking COVID-19 infections.

A*STAR scientists decipher how a stem cell-based treatment stops the uncontrolled inflammation associated with severe COVID-19 cases.

Using a new genome analysis technology, A*STAR scientists discover never-before-seen immune responses in tuberculosis infections.

A new polymer gel may offer a drug-free solution to preventing retinal scarring after eye surgery.

Scientists discover a potential therapeutic target to tackle a dangerous drug-resistant yeast strain.

A protein called Agrin naturally produced in the skin could soon be the active ingredient in a treatment to boost skin repair in non-healing wounds.

More evidence emerges that fatty foods change skin composition, creating the perfect conditions for acne flare-ups.

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

A profile of the immune responses from Singaporean patients recovered from COVID-19 has revealed an urgent need to update vaccines against new viral variants.

Fine-tuning the levels of three skin cell metabolites could be the key to unlocking treatments for psoriasis and ageing skin.

A deletion in the genome of SARS-CoV-2 variants makes resulting infections milder and could also be a target for future COVID-19 treatments.

A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.